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When examined in metaphase chromosome prepara-
tions, all fragile sites appear as a gap or discontinuity
in chromosome structure. These gaps, which are induced
by several specific treatments of cultured cells, are of
variable width and promote chromosome breakage with
variable efficiency. Within a single metaphase, it is not
possible to distinguish between a fragile site and random
chromosomal damage. Only the statistically significant
recurrence of a lesion at the same locus and under the
same culture conditions delineates fragile sites. Several
classes of fragile sites have now been characterized at
the molecular level. The “rare” fragile sites contain tan-
demly repeated sequences of varying complexity, which
undergo expansions or, occasionally, contractions. The
common fragile sites remain as enigmatic at the molec-
ular level as the rare ones once were at the genetic level
(Sutherland 1985).
The cytogenetic expression of a fragile site is but one
manifestation of genomic instability that is generated by
the DNA sequences at fragile-site loci. For instance, the
rare folate-sensitive fragile sites are associated with tran-
scriptional silencing of genes, and some of the common
fragile sites may also affect gene expression by creating
local regions of chromosomal instability. The current
challenge is to understand the mechanisms of this insta-
bility and its biological significance.
Fragile sites are classified according to their frequency
and the conditions or agents that induce their expression
(Sutherland et al. 1996). Common fragile sites appear
to be part of normal chromosomal structure and are
probably present at all common fragile-site loci in all
individuals. Rare fragile sites vary in frequency from
only a handful of case reports up to 1 in 40 chromo-
somes. A classification of fragile sites and some details
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of their cytogenetic and molecular properties are given
in table 1.
Fragile sites are identifiable as gaps or chromosomal
breaks in only a fraction of metaphase spreads from a
given individual. At one extreme is FRA16B, which,
when induced by berenil, may be found in 190% of
metaphases (Schmid et al. 1986). At the opposite end of
the spectrum are the common aphidicolin fragile sites.
Even the most conspicuous of these, FRA3B, is rarely
seen in 110% of metaphases (Smeets et al. 1986), and
many of the other common fragile sites are seen in !5%
of metaphases. Whatever the mechanisms are that result
in fragile-site expression, they usually operate success-
fully in only a minority of cells.
Most of the treatments that induce fragile sites (e.g.,
perturbed nucleotide pools and aphidicolin) result in
slowing DNA replication, particularly at fragile-site loci
(Hansen et al. 1997; Le Beau et al. 1998). It is thus
possible that the common fragile sites, and perhaps the
rare ones, arise because of incompletely replicated DNA
sequences that do not package completely for mitosis.
Whereas such packaging is completed in most cells, in
a varying, often small proportion of cells it may not be
completed before the end of G2, and it is in these cells
that fragile sites manifest themselves as gaps or breaks.
Sequences of Fragile Sites
Only three of the different classes of rare fragile sites
have been studied at the molecular level. Most is known
about the rare folate-sensitive fragile sites, of which five
members have been cloned. This group includes
FRAXA, the site of the molecular lesion in the fragile
X syndrome gene FMR1, which underlies the most com-
mon familial form of mental retardation.
The normal alleles at the FRAXA locus vary in size
from ∼6–55 CCG repeats, mostly with interspersedCCT
units after every 9–10 CCG units (Hirst et al. 1994),
although there is variation in this pattern, with some
alleles having no or only one CCT unit. In Tunisian Jews,
there is an increased incidence of normal alleles without
CCT units, and this is likely to be the basis of an ap-
parently high incidence of fragile X syndrome in this
ethnic group (Falik-Zaccai et al. 1997). The increased
length of premutation and mutation alleles appears to
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Table1
Classification and Some Properties of Fragile Sites
Class Induced by
Number
Recognized
Number
Cloned Repeat Motif
Rare:
1. Folate sensitive Low folate and thymidine, FUdR, MTX, high thymidine 23 5 CCG
2. Distamycin A inducible a. Distamycin A, other minor groove-binding oligopeptide
antibiotics, and BrdU 2 1 33 bp AT-rich
b. As above, but not BrdU (recorded only in the
Japanese) 3 0 )
3. BrdU inducible BrdU or BrdC 2 1 ∼42 bp variable AT-rich
Common:
4. Aphidicolin inducible Aphidicolin for at least 24 h 76 3 None obvious
5. 5-Azacytidine inducible 5-Azacytidine for no more than 8 h 4 0 )
6. BrdU inducible BrdU for no more than 8 h 6 0 )
7. Adenovirus 12
inducible
Adenovirus 12 in U1 small nuclear RNA genes in
p53-expressing cells 4 0 )
be due to increased numbers of CCG units alone. Fur-
thermore, the alleles that expand to give pre- and full
mutations are in linkage disequilibrium with microsat-
ellite (Richards et al. 1992) and single nucleotide poly-
morphisms (SNPs; Gunter et al. 1998) within the gene
or close to its 5′ end. The presence of one of these SNPs,
ATL1, can be used to predict which alleles are likely to
proceed to expansion (Gunter et al. 1998), although it
is unlikely that the ATL1 polymorphism, in the first in-
tron of FMR1, has functional significance in relation to
expansion. More likely, it is in linkage disequilibrium
with some CCG repeat structure that promotes expan-
sion.
The only other folate-sensitive fragile site for which
there is information on allele structure is FRA16A (Nan-
carrow et al. 1995). As with FRAXA, some of the longer
alleles that lack CCT interruption might be expected to
undergo expansion more readily than interrupted alleles.
However, too few expanded alleles are available for
study to test this prediction rigorously.
The cloning of FRA16B showed that repeat sequences
other than trinucleotides could undergo expansion and
result in a fragile site (Yu et al. 1997). At this locus, a
33-bp AT-rich repeat, which is highly polymorphic on
normal chromosomes, expands up to several thousand
copies to yield a fragile site. Such large expansions can
be viewed only on pulse-field gels, where variation in
size by a relatively small number of copies would not
be resolved. Hence, although the expansions in different
families with FRA16B are clearly distinct, neither size
variation within families nor somatic instability in car-
riers of this fragile site has been observed.
Fragile site FRA10B differs from FRA16B in that,
whereas the former is induced only by nucleotide ana-
logues such as BrdU or BrdC, the latter is also (indeed,
more strongly) induced by DNA minor groove-binding
agents such as distamycin A and berenil. FRA10B is the
most complex fragile site yet studied. It is an expansion
of 5–100 kb, consisting of an AT-rich minisatellite repeat
unit of ∼42 bp in length, which varies in size and com-
position between families (Hewett et al. 1998). The ex-
panded sequence shows both somatic and intergenera-
tional instability.
Three common fragile sites (FRA3B, FRA7G, and
FRA7H) have also been studied in some detail (Mishmar
et al. 1998). In contrast to the rare fragile sites, here the
fragility occurs over a region of tens to hundreds of
kilobases rather than at a single point. Sequence analysis
of these regions reveals no striking features that could
account for the fragile site, although there are regions
of decreased stability and increased flexibility of the
DNA that might be significant (Mishmar et al. 1998;
Palin et al. 1998). FRA3B occurs within the FHIT gene,
but the other two fragile sites are not known to be within
genes. These common fragile sites are late-replicating
regions, and it is of interest that aphidicolin, which in-
duces these fragile sites, further delays their replication
(Le Beau et al. 1998). This finding supports the model
that these fragile sites may simply represent very
late–replicating regions of DNA, which, in a minority
of cells, fail to complete replication before mitosis begins
and, for this reason, do not package well into chro-
mosomes.
A common aphidicolin type fragile site in the Chinese
hamster has been cloned on the basis of its increased
sensitivity for the incorporation of a linearized plasmid
containing a selectable drug-resistance marker. Sequence
analysis showed the region of the fragile site to be AT-
rich, with a number of other features, including ho-
mologies to yeast autonomous replicating sequences and
a consensus sequence for replication origins (Palin et al.
1998). Fragile sites inducible by adenovirus 12 occur in
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Figure 1 CCG repeat instability and methylation at the FRAXA locus during male and female development. FRAXA is the best-studied
such site, but some of the observations depicted here probably apply at other fragile sites as well.
the small nuclear RNA gene clusters but only in cells
expressing p53. It has been postulated that a viral pro-
tein causes p53 to undergo a gain of function, leading
either to perturbed transcription by RNA polymerase II
or to inefficient chromatin condensation. As Li et al.
(1998) note, continued replication or transcription be-
yond G2 might be expected to interfere with chromatin
compaction.
The Induction of Instability at Fragile Sites
Although fragile sites are themselves visual manifes-
tations of genome instability, there is considerable evi-
dence that genome instability at these loci occurs at other
levels. Because most or all of the rare fragile sites are
prone to intergenerational and somatic repeat expan-
sion, it is worth considering how this instability comes
Sutherland and Richards: Human Genetics ’99 357
about. In the case of FRAXA, the best-known example,
certain normal alleles can increase in size from within
the normal range of copy numbers into the premutation
range. Mechanisms to account for instability include un-
equal crossing over, gene conversion, and replication
slippage (see Sinden 1999 [in this issue]). These events
are apparently rare, and the rate at which they occur is
probably little different from the mutation rate of other
simple tandem repeats (∼103 per locus/generation).
Once the number of uninterrupted repeats exceeds ∼80,
the length of an Okazaki fragment, replication slippage
is likely to be the predominant mechanism by which
increasingly larger size changes occur, the process of dy-
namic mutation (Richards and Sutherland 1994; Suth-
erland et al. 1998). This model has recently received
experimental support (Freudenreich et al. 1998; Sarkar
et al. 1998).
Superimposed on this process are a number of factors
such as the age and sex of the individual in which the
changes occur. The most likely series of events in the
genesis of an individual with a FRAXA full mutation is
shown in figure 1. An ovum with a full mutation is
produced (by either a pre- or a full mutation carrier)
and fertilized. This full mutation is unmethylated (Mal-
ter et al. 1997), and it remains so throughout early em-
bryogenesis. The unmethylated mutation is somatically
unstable and gives rise to cell lineages with different
numbers of copies of the repeating unit. Most of these
are probably breakdown products with fewer copies of
the repeat than are found in the ovum, but some may
contain additional copies. Once the expanded repeat un-
dergoes CpG methylation, further changes in repeat
copy number are rare. Methylation is probably not com-
plete until 12–14 weeks of gestation. At least in the case
of the FMR1 gene, methylation also leads to transcrip-
tional silencing of the allele on the fragile X chromo-
some. In the male fetus, there is premeiotic selection
against germ cells that contain the full mutation in favor
of cells with a premutation (Ashley-Koch et al. 1998).
Eventually spermatogenesis results in sperm with pre-
mutations only. However, no selection occurs in the
ovary of a female fetus, so full mutations persist in the
female germline. During oogenesis, when CpG methyl-
ation is erased, instability is restored to the CCG repeat,
and ova with different-sized mutations are generated.
Finally, as individuals age, there is very slow selection
against somatic cells with the largest alleles (Ashley-
Koch et al. 1998). In females, there is slow selection
against cells in which the fragile site is on the active X
chromosome (Rousseau et al. 1991). It is likely that this
series of events is also applicable to FRAXE but not
entirely to the autosomal sites. Thus, full mutations in
FRA16A do not appear to be subject to selection in male
germ cells (Nancarrow et al. 1994).
Although intergenerational and somatic instability
can occur at FRA10B and probably also at FRA16B,
the rates at which these changes occur are much lower
than at folate-sensitive fragile sites, perhaps because rep-
lication slippage is less likely with longer-repeat motifs.
Other mechanisms, such as gene conversion, may ac-
count for changes in allele size at FRA10B and FRA16B
(Jeffreys et al. 1994). Genomic instability at the common
fragile sites has been documented extensively for FRA3B
and to a lesser extent for FRA7G (Huang et al. 1998).
Instability at FRA3B occurs by recombination between
long L1 sequences (Inoue et al. 1997) and generates de-
letions in the FHIT gene in a range of solid tumors.
FRA7G is within an area of instability in prostate can-
cers, but the mechanism of its instability has not been
determined.
Other manifestations of genomic instability at FRA3B
include its function as a target for viral integration, spe-
cifically of HPV16. There is also evidence for the com-
mon fragile sites being involved in gene amplification by
being points of breakage in a breakage-fusion bridge
mechanism (Coquelle et al. 1998).
The Biological Significance of Fragile Sites
The biological significance of chromosomal fragility
is not easily generalized among fragile loci. Two of the
rare fragile sites on the X chromosome are manifesta-
tions of disease (mental retardation)–producing dynamic
mutations, whereas the third rare fragile site on this
chromosome, FRAXF, is not found within any known
gene and does not lead to any obvious phenotypic ab-
normality. The autosomal fragile sites of this type may
be associated with transcriptional silencing of genes in
which they might be located. Breakage at fragile sites
may be capable of producing chromosomal deletion syn-
dromes, as perhaps occurs when FRA11B breakage leads
to Jacobsen syndrome (Jones et al. 1995). It is of interest
that none of the rare folate-sensitive fragile sites has been
identified in species other than humans, yet repeats that
are potentially capable of expansion to fragile sites have
been identified in other species.
Fragile sites are probably all associated with localized
genomic instability; although this instability might lead
only to the “gap” seen in cytogenetic preparations, it is
also possible that the consequences are more significant.
There is growing evidence that some common fragile
sites predispose their surrounding region to the localized
chromosomal instability seen in certain cancers. FRA3B
is one such region of instability, and abnormal tran-
scripts of the FHIT gene in which it is located are found
in a range of tumor and normal cell types (Siprashvili
et al. 1997; Carapeti et al. 1998; Otterson et al. 1998).
The human caveolin genes CAV1 and CAV2 are located
in the vicinity of FRA7G, which is frequently deleted in
human cancers (Engelman et al. 1998b). Caveolin-1 has
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been shown to have a role in the anchorage-dependent
inhibition of growth in NIH 3T3 cells (Galbiati et al.
1998). The caveolins are therefore candidates for the
tumor-suppressor gene presumed to be located in the
FRA7G region (Engelman et al. 1998a). By similar
mechanisms, fragile sites may also lead to gene ampli-
fication in tumors. The noncompacted state of the DNA
at fragile sites may also facilitate the integration of vi-
ruses into the genome.
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